This list is an analysis based on recent market events. It's not an investment recommendation.
About
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
The current price of LBRX is $35.41 USD — it has increased by +3.63% in the past 24 hours. Watch LB Pharmaceuticals stock price performance more closely on the chart.
What is LB Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange LB Pharmaceuticals stocks are traded under the ticker LBRX.
What is LB Pharmaceuticals market cap?▼
Today LB Pharmaceuticals has the market capitalization of 967.55M
When is the next LB Pharmaceuticals earnings date?▼
LB Pharmaceuticals is going to release the next earnings report on September 02, 2026.
What were LB Pharmaceuticals earnings last quarter?▼
LBRX earnings for the last quarter are -0.67 USD per share, whereas the estimation was -0.75 USD resulting in a +10.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LB Pharmaceuticals revenue for the last year?▼
LB Pharmaceuticals revenue for the last year amounts to 0 USD.
What is LB Pharmaceuticals net income for the last year?▼
LBRX net income for the last year is -25.21M USD.
How many employees does LB Pharmaceuticals have?▼
As of July 10, 2026, the company has 16 employees.
In which sector is LB Pharmaceuticals located?▼
LB Pharmaceuticals operates in the Health & Wellness sector.
When did LB Pharmaceuticals complete a stock split?▼
LB Pharmaceuticals has not had any recent stock splits.
Where is LB Pharmaceuticals headquartered?▼
LB Pharmaceuticals is headquartered in New York, United States.